Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease

Laryngoscope

Volumn 124, Issue 4, 2014, Pages 888-895

  Vazquez, Alejandro ^a   Khan, Mohemmed N ^a   Blake, Danielle M ^a   Sanghvi, Saurin ^a   Baredes, Soly ^a,b   Eloy, Jean Anderson ^a,b,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

^c New Jersey Medical School   (United States)

Author keywords

T cell lymphoma; Extranodal NK; nasal lymphoma; paranasal sinus lymphoma; sinonasal lymphoma; sinonasal NK T cell lymphoma incidence; sinonasal NK T cell lymphoma survival

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISEASE SURVEILLANCE; EXTRANASAL EXTRANODAL NATURAL KILLER CELL LYMPHOMA; FEMALE; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HUMAN; ICD-O-3; INCIDENCE; KAPLAN MEIER METHOD; LYMPHATIC SYSTEM; MALE; MAXILLARY SINUS; MIDDLE AGED; NK T CELL LYMPHOMA; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; SINONASAL EXTRANODAL NATURAL KILLER CELL LYMPHOMA; STUDENT T TEST;

/T-CELL LYMPHOMA; EXTRANODAL NK; NASAL LYMPHOMA; PARANASAL SINUS LYMPHOMA; SINONASAL LYMPHOMA; SINONASAL NK/T-CELL LYMPHOMA INCIDENCE; SINONASAL NK/T-CELL LYMPHOMA SURVIVAL;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; NEOPLASM STAGING; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84896549611     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24371     Document Type: Article

References (34)

1. Chan ACL, Cheung JKC, Kapadia MMC,. Hematolymphoid tumors. In:, Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005: 58-64.
2. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES,. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117: 5019-5032.
3. Chan JKC, Q-ML, Ferry, JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In:, Swerdlow SH, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008: 285-288.
4. Rao T,. Lethal granulomatous ulceration of midline of the face. Indian J Otolaryngol 1954; 6: 91-98.
5. Williams HL,. Lethal granulomatous ulceration involving the midline facial tissues. Ann Otol Rhinol Laryngol 1949; 58: 1013-1054.
6. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
7. Barrionuevo C, Zaharia M, Martinez MT, et al. Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 2007; 15: 38-44.
8. Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009; 113: 3931-3937.
9. Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol 2013; 37: 14-23.
10. Gui W, Zhao Z, Shen Q, et al. The clinical study of extranodal natural killer cell lymphoma, nasal type. Med Oncol 2011; 28 (suppl 1): S367-S372.
11. Lee J, Park YH, Kim WS, et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005; 41: 1402-1408.
12. Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol 2008; 20: 619-625.
13. Ren YL, Nong L, Zhang S, Zhao J, Zhang XM, Li T,. Analysis of 142 Northern Chinese patients with peripheral T/NK-Cell lymphomas: subtype distribution, clinicopathologic features, and prognosis. Am J Clin Pathol 2012; 138: 435-447.
14. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612-618.
15. Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004; 100: 366-375.
16. Suzuki R, Suzumiya J, Yamaguchi M, et al. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol 2010; 21: 1032-1040.
17. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual. New York, NY: Springer-Verlag; 2002.
18. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M,. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860-1861.
19. Sarfati D, Blakely T, Pearce N,. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol 2010; 39: 598-610.
20. Yu B, Tiwari RC, Cronin KA, McDonald C, Feuer EJ,. CANSURV: a Windows program for population-based cancer survival analysis. Comput Methods Programs Biomed 2005; 80: 195-203.
21. Mendenhall WM, Olivier KR, Lynch JW Jr, Mendenhall NP,. Lethal midline granuloma-nasal natural killer/T-cell lymphoma. Am J Clin Oncol 2006; 29: 202-206.
22. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996; 20: 103-111.
23. Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 1999; 23: 1356-1369.
24. Jo JC, Yoon DH, Kim S, et al. Clinical features and prognostic model for extranasal NK/T-cell lymphoma. Eur J Haematol 2012; 89: 103-110.
25. Ko YH, Ree HJ, Kim WS, Choi WH, Moon WS, Kim SW,. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer 2000; 89: 2106-2116.
26. Liang R,. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol 2009; 147: 13-21.
27. Kohrt H, Advani R,. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leuk Lymphoma 2009; 50: 1773-1784.
28. Gill H, Liang RH, Tse E,. Extranodal natural-killer/t-cell lymphoma, nasal type. Adv Hematol 2010;2010: 627401.
29. Lee PY, Freeman NJ, Khorsand J, Weinstock MA,. Angiocentric T-cell lymphoma presenting as lethal midline granuloma. Int J Dermatol 1997; 36: 419-427.
30. Sakata K, Hareyama M, Ohuchi A, et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol 1997; 36: 307-311.
31. Koch M, Blatterspiel GJ, Niedobitek G, Constantinidis J,. Angiocentric T/NK cell lymphoma: a special clinical-pathological entity of lethal midline granuloma. A case report [in German]. Laryngorhinootologie 2001; 80: 410-415.
32. Chen HH, Fong L, Su IJ, et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period. Radiother Oncol 1996; 38: 1-6.
33. Ishida F, Kwong YL,. Diagnosis and management of natural killer-cell malignancies. Expert Rev Hematol 2010; 3: 593-602.
34. Tigges G, Delank KW, Blasius S, Stoll W,. Nasal T-cell lymphoma as a differential diagnosis of the midline granuloma syndrome [in German]. Laryngorhinootologie 1999; 78: 139-143.